Use of Allied-health Professionals to Improve Treatment of Disease
ConditionPreeclampsia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorUniversity of Iowa
About this trial
The goal of this clinical trial is to learn if allied-health professionals can recruit and follow research participants, sustain engagement, and improve and diagnose treatment of diseases by facilitating transitions of care.
Participants will:
Take their blood pressure at home and return it to the research team; Follow up with a research pharmacist for 12 months; Return for a follow up visit after 12 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Biological mothers delivering at UIHC or attending a well-child visit for an infant between 1 month and 9 months
Preeclampsia during pregnancy
Preceived prenatal care at UIHC
Owns a smartphone
Disqualifiers
Arm circumference greater than 17 inches
Prisoner status
Unable to provide own written informed consent
Trial design
Design model
Single group
Treatments tested in this trial
Research Pharmacist
BehavioralThe goal of this intervention is to determine if allied health professionals will improve blood pressure in new mothers.
Treatment groups
200 Participants
are divided into 1 treatment groupGroup A: Research Pharmacist MonitoringExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Number of Subjects at Risk for Hypertension
We will calculate the number of participants who are at risk for hypertension during the course of the intervention.
Time frame
Through study completion, an average of 12 months2
Number of Subjects Exposed to a Screening Clinic
We will calculate the number of participants who visited a screening clinic during the course of the intervention.
Time frame
Through study completion, an average of 12 months3
Number of Subjects Screened at a Screening Clinic
We will calculate the number of participants who were screened at a screening clinic during the intervention.
Time frame
Through study completion, an average of 12 months4
Number of Subjects Followed-Up by the Research Pharmacist
We will calculated the number of participants who were followed-up by a research pharmacist during the intervention.
Time frame
Through study completion, an average of 12 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: